Dr. Nielsen on the Pros and Cons of the Ki67 Assay in Breast Cancer
Ki67, what is it and why is it controversial?
The use of the Ki-67 in deciding which patients with HR+ breast cancer can safely avoid chemotherapy
What are the grades and stages of breast cancer?
Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes...
Ki-67 index after neoadjuvant ET as a prognostic biomarker for HR+/HER2- early breast cancer
LUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT
Dr. Ellis Discusses Ki67 as a Treatment Monitoring Biomarker
Dr. Nielsen on the Clinical Utility of Ki67 in Breast Cancer
Dr. Nielsen Discusses Using a Ki67 Assay in Breast Cancer
Who gets Breast Cancer Recurrences? - with Dr Tasha
Treatment Options for Stage II (2) Breast Cancer: Everything You Need to Know
Oncotype DX in Early Stage Breast Cancer
What are the stages of breast cancer
Doctor Explains Cancer Grade
Oncotype DX for Breast Cancer
Dr. Mamounas on Recurrence Rates in Breast Cancer
Role of the Oncotype DX Breast Recurrence Score Test
The use of Ki-67, a proliferation marker, for guiding treatment decisions in breast cancer patients
Ki-67: Explained!!! #Medschooldiscussion
